Microbe Breaks Biology's 60-Year Rule: The Same DNA 'Stop' Signal Can Now Mean Two Different Things

For six decades, one of biology's most fundamental rules has been the unambiguous nature of the genetic code: every three-letter DNA sequence, called a codon, maps to exactly one outcome — either a specific amino acid is added to a growing protein, or construction stops entirely. UC Berkeley researchers have now overturned that rule, discovering a living organism in which the "stop" signal for protein synthesis sometimes doesn't stop at all, functioning instead as an instruction to insert an unusual amino acid and continue building.

The organism is Methanosarcina acetivorans, a methane-producing member of the Archaea — the ancient, evolutionarily distinct domain of life separate from bacteria and from all nucleated cells including our own. In experiments published in the Proceedings of the National Academy of Sciences in November 2025 and widely reported in early 2026, Dr. Dipti Nayak and her lab at UC Berkeley found that this archaeon reads the UAG codon — universally recognized across life on Earth as a stop signal — in two completely different ways. Sometimes UAG ends protein synthesis as expected. Other times, it directs the cell to insert the unusual amino acid pyrrolysine and continue building the protein. Whether the codon acts as a stop or a "go" depends partly on how much pyrrolysine is available inside the cell at that moment.

The implications are far-reaching. Between 200 and 300 of the organism's genes contain UAG codons, meaning a substantial fraction of its entire protein repertoire potentially exists in two different forms depending on cellular conditions. "The UAG codon is like a fork in the road, where it can be interpreted either as a stop codon or as pyrrolysine," said Katie Shalvarjian, the lead author and now a postdoctoral researcher at Lawrence Livermore National Laboratory. Nayak described the broader significance more bluntly: "Ambiguity in the genetic code should be deleterious — you end up generating a random pool of proteins. But biological systems are more ambiguous than we give them credit for, and that ambiguity can be a feature, not a bug."

The mechanism appears to have evolved because pyrrolysine is essential for enzymes that digest methylamine, a nitrogen-containing compound abundant in certain environments and in the human gut. By using an ambiguous codon to incorporate pyrrolysine only when the amino acid is present, the microbe may gain flexibility to tune its enzyme production to match food availability — a form of metabolic adaptability not previously described at the level of the genetic code itself. These archaea also perform a medically relevant function in the gut: they consume methylamines that would otherwise be converted by the liver into trimethylamine N-oxide, or TMAO, a compound associated with increased cardiovascular disease risk in people who eat red meat.

Perhaps the most immediate medical implication lies in a class of genetic diseases caused by premature stop codons — mutations that insert a UAG, UAA, or UGA stop signal in the middle of a gene, truncating the protein before it is complete. Approximately 10% of all inherited genetic diseases fall into this category, including cystic fibrosis, Duchenne muscular dystrophy, and some forms of inherited cancer predisposition. Understanding how Methanosarcina acetivorans tolerates — and actively exploits — stop codon ambiguity in hundreds of genes without apparent harm could inform new gene therapy and drug development strategies aimed at making premature stop codons "leaky" in patient cells, allowing production of enough full-length protein to alleviate symptoms. The discovery represents a genuine expansion of what biologists thought was possible within the framework of life's most basic informational machinery.